Quick Summary

Grapefruit (Citrus paradisi) is a citrus fruit studied for its bioactive components including flavonoids such as naringin and hesperidin. These compounds have been investigated for potential cardiovascular, antioxidant, anti-inflammatory, and drug delivery properties. Research includes clinical trials, randomized controlled trials, and preclinical studies examining effects on cardiovascular risk factors, interactions with the CYP3A4 enzyme, and possible health benefits. Evidence for grapefruit-related interventional efficacy is mixed, with notable concerns regarding interactions affecting drug metabolism. Safety data indicate a significant potential for drug interactions, primarily via inhibition of cytochrome P450 enzymes.

What is it

Grapefruit is a subtropical citrus fruit known scientifically as Citrus paradisi. It contains a range of bioactive compounds, particularly flavonoids like naringin and hesperidin, which contribute to its biological activity. It is consumed fresh, as juice, and as part of various supplements.

Traditional Uses

Traditionally, grapefruit has been used in dietary practices for general health promotion. Its components have been explored for cardiovascular support and respiratory health. Additionally, essential oils derived from grapefruit and other citrus fruits have been used in aromatherapy for relaxation and sleep improvement.

Active Compounds

  • Naringin: A major flavonoid with antioxidant and anti-inflammatory properties.
  • Hesperidin: A flavonoid studied for potential antiviral, antioxidant, and immunomodulatory effects.
  • Polyphenols: Contribute to antioxidant and anti-inflammatory activity.
  • Furanocoumarins: Present in grapefruit juice and known to affect drug metabolism enzymes.

Potential Benefits with Evidence Levels

  • Cardiovascular risk factor improvement

    Moderate clinical evidence: A randomized, double-blind controlled trial (n=51 intervention, n=45 placebo) found that a grapefruit-containing supplement improved flow-mediated vasodilation, blood pressure, lipid profiles, oxidative stress, and inflammatory biomarkers after eight weeks in healthy volunteers (PMID:32438719).
  • Endothelial and cardiovascular effects of naringin

    Limited human clinical and preclinical evidence: Systematic reviews indicate antioxidant, anti-inflammatory, and vasoprotective effects in animal models and limited human trials suggest improvements in lipid profile and arterial stiffness (PMID:40871686).
  • Potential antiviral effects of hesperidin against SARS-CoV-2

    Preclinical and computational evidence: Computational studies suggest hesperidin can bind SARS-CoV-2 proteins with high affinity and may exhibit antioxidant and immunomodulatory effects (PMID:32823497).
  • Improvement of sleep problems via inhalation aromatherapy including grapefruit

    Systematic review with meta-analysis (aromatherapy generally): Aromatherapy using citrus essential oils, including grapefruit, may help improve sleep issues like insomnia, although lavender showed the greatest effect; this is based on analysis of 34 studies (PMID:33655928).
  • Potential antioxidant and anti-inflammatory bioactivities

    Preclinical and ethnopharmacological evidence: Grapefruit flavonoids and polyphenols have demonstrated antioxidant and anti-inflammatory effects in vitro and animal studies (PMIDs:37569540, 37229273).

Side Effects

  • Local cutaneous irritation has been reported with certain plant-based therapies, but specific adverse effects of grapefruit itself are not well characterized.
  • Potential for herb-drug interactions that may cause unexpected side effects due to increased plasma levels of certain medications.

Drug Interactions

  • Inhibition of CYP3A4 metabolism: Grapefruit juice and pomelo juice can significantly increase plasma levels of drugs metabolized by CYP3A4 (e.g., cyclosporine, midazolam), which may lead to adverse effects (PMIDs:27278683, 27503364).
  • Potential interaction with P-glycoprotein and other drug transporters: Citrus components may alter drug transporter activity, potentially influencing the pharmacokinetics of coadministered drugs (PMID:36223846).

Who Should Avoid It

Individuals using medications metabolized by CYP3A4 should exercise caution or avoid grapefruit products due to the risk of significant drug interactions. Pregnant or breastfeeding women should also exercise caution, as direct safety data are lacking and potential drug interaction risks exist.

Evidence Limitations

  • There is a limited number of high-quality randomized controlled trials directly assessing grapefruit’s clinical efficacy for specific health conditions.
  • Much of the evidence derives from preclinical studies, computational analyses, or combined botanical formulations, complicating isolation of grapefruit-specific effects.
  • Small sample sizes and short durations in clinical studies restrict the robustness of conclusions.
  • Variability in grapefruit juice composition, particularly furanocoumarin content, affects the consistency and reproducibility of drug interaction risk assessments.
  • Extensive safety data for long-term use and in special populations such as pregnant women are lacking.

References

  • PMID: 32438719 – Randomized controlled trial on grapefruit, bitter orange, and olive extracts showing cardiovascular risk improvement in healthy subjects.
  • PMID: 40871686 – Systematic review on endothelial and cardiovascular effects of naringin, a major flavonoid of grapefruit.
  • PMID: 32823497 – Computational studies on hesperidin’s potential antiviral effects against SARS-CoV-2.
  • PMID: 33655928 – Systematic review and meta-analysis of inhalation aromatherapy including citrus oils for sleep improvement.
  • PMID: 27278683 – Systematic review and meta-analysis on interaction of citrus juices with cyclosporine.
  • PMID: 27503364 – Clinical study on midazolam pharmacokinetics altered by grapefruit juice low in furanocoumarins.
  • PMID: 41901427 – Review on plant-derived extracellular vesicles including grapefruit-derived nanocarriers reporting preliminary human safety data.
  • PMID: 36223846 – Screening of medicinal plants for potential herb-drug interactions including effects on metabolism and transporters.

Last Reviewed

June 2024

Disclaimer: This information is provided for educational purposes only. Grapefruit and its components may interact with medications and affect health conditions. Consult a healthcare professional before using grapefruit or related products, especially if you are taking prescription medications, are pregnant, breastfeeding, or have underlying health concerns. No medical promises or guarantees are made regarding the efficacy or safety of grapefruit based on the current evidence.